Bellicum Pharmaceuticals, Inc. (BLCM) earnings
Quarterly and annual BLCM reports and results, each read against the price at its own news timestamp. Back to the BLCM overview →
1 measured BLCM earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q BELLICUM PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +19.05% |
Keep exploring
More BLCM: analyst actions → · SEC filings → · BLCM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Acer Therapeutics Inc. (ACER) | 38 | -1.46% | 23% |
| Aeglea BioTherapeutics, Inc. (AGLE) | 38 | 0.00% | 22% |
| Medx Health Corp (MDX_CDNX) | 38 | 0.00% | 38% |
| MEDICURE INC (MCUJF) | 37 | 0.00% | 11% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.